Search Medical Condition
Please enter condition
Please choose location

Negrar - Verona, Italy Clinical Trials

A listing of Negrar - Verona, Italy clinical trials actively recruiting patients volunteers.

RESULTS

Found (62) clinical trials

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

OBJECTIVES: Primary - To compare the activity of sunitinib malate when administered before vs after cytoreductive nephrectomy, in terms of response rate, in patients with metastatic renal cell carcinoma. - To compare the safety of these regimens in these patients. Secondary - To compare the time to progression in patients ...

Phase

0.0 miles

Learn More »

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer.

Patients will be randomised in 1:1 ratio to either olaparib or placebo. Randomisation will be stratified by Hormone receptor status (ER and/or PgR positive/HER2 negative versus TNBC), prior neoadjuvant versus adjuvant chemotherapy and prior platinum use for breast cancer. Randomised patients will receive study treatment for up to a maximum ...

Phase

0.0 miles

Learn More »

Reveal LINQ Registry

The study is a prospective, non-randomized, observational, multi-center, global study. The study will characterize clinical actions initiated by Reveal LINQ arrhythmia detection and estimate procedure-related acute infection rate. Approximately 1,500 subjects will be implanted with a Reveal LINQ ICM and undergo continuous remote monitoring and be followed prospectively from insertion ...

Phase N/A

0.0 miles

Learn More »

Italian ClinicalService Project

The mission of the Italian ClinicalService Project is to improve outcomes and comprehension of diagnostic and therapeutic strategies applied to patients wearing Medtronic implantable devices. ClinicalService provides services to evaluate and improve the quality of clinical care in the Italian clinical practice. ClinicalService collects acute and chronic patient and device ...

Phase N/A

0.0 miles

Learn More »